Texas Instruments: Checking the Operational Torque in Q2 2026
Texas Instruments filed its Q2 2026 10-Q on July 24, and the headline numbers invite scrutiny: earnings per share jumped 28% from Q1 to Q2, and pre-tax income climbed 31% in the same quarter. Before crediting discipline and demand, a careful observer should separate genuine operational improvement from the accountant's sleight of hand that often works in semiconductor companies' favor during cyclical upswings.
The Numbers: Real But Compressed
TXN's Q2 fundamentals are solid: revenue expanded 13.2% quarter-over-quarter to $5.463 billion from $4.825 billion. Gross profit rose 19.8% to $3.352 billion, and operating income surged 27.8% to $2.310 billion. Net income available to common shareholders hit $1.969 billion, up 28.2%.
The temptation is to call this evidence of flawless execution. But context matters. Year-over-year, the picture is more modest: Q2 2026 revenue of $5.463 billion compared to Q2 2025's $4.448 billion shows 22.8% growth, while EPS expanded only 52% on a smaller base ($1.42 vs $2.16). That's strong, but the quarterly growth rate of earnings masks an important truth: EPS growth on a trailing twelve-month basis sits at just 4.8%, according to the company's own calculated metrics.
The recent acceleration is real but unsustainable if it rests on temporary cost leverage rather than durable competitive advantage.
The Cost Ratio: Where the Leverage Lives
The operational story turns on one number: cost of goods as a percentage of revenue.
In Q1 2026, TXN spent $2.026 billion to produce $4.825 billion in revenue, yielding a cost ratio of 42.0%. In Q2, that ratio compressed to 38.6%, even as gross spending rose to $2.111 billion on higher output. This 340-basis-point improvement is not typical noise; it reflects either significant manufacturing efficiency gains, favorable product mix, or aggressive pricing power in a tight market.
For a semiconductor manufacturer with integrated fabs and deep process expertise, such gains are possible but carry a caveat: they can evaporate as quickly as demand softens or manufacturing yields normalize. The company's quarterly capex (for PP&E) was actually lower in Q2 ($514 million) than Q1 ($676 million), suggesting TXN is harvesting output from existing capacity rather than racing to expand. That's prudent, but it also implies management is cautious about the durability of the current demand environment.
Segment Strength: Analog Carries the Load
TXN's business breaks into three segments: Analog, Embedded Processing, and Other. In fiscal 2025, Analog represented 73.8% of revenue ($13.04 billion) and 79.4% of operating profit ($5.821 billion). This is not a diversified conglomerate; it is a company riding one wave.
Analog semiconductors serve industrial, automotive, and power-management applications. These markets have been resilient during 2025 and early 2026, driven by AI infrastructure buildout and industrial automation. But the concentration risk is real. If industrial demand stutters or automotive production slows, TXN's profitability will compress faster than the equity markets typically expect.
Capital Allocation: Dividends and Buybacks
In Q2 2026, TXN returned cash to shareholders: $1.295 billion in dividends and only $27 million in buybacks, compared to Q1's $1.291 billion and $158 million respectively. Over the full year 2025, the company paid $4.999 billion in dividends and spent $1.477 billion on share repurchases.
This allocation reflects a mature company that values steady dividend income over aggressive EPS accretion through buybacks. The dividend yield stands at 2.0%, reasonable for a technology company but modest against a 10-year Treasury. The company's operating cash flow in Q2 was $2.703 billion, solid enough to fund both distributions and investment, though free cash flow metrics show earnings yield of just 2.37%.
TXN is not starved for cash, but it is neither sacrificing near-term earnings for long-term positioning. The capital discipline is measured, not aggressive.
Valuation: Pricing in Growth That May Not Arrive
The stock trades at a P/E of 42.2, a price-to-sales ratio of 13.1, and a PEG ratio of 5.4. These are not cheap valuations. Even adjusting for quality, a PEG of 5.4 implies the market is pricing in either continued acceleration in earnings growth or a sustained period of elevated profitability margins. The recent quarter's EPS acceleration (28% Q-over-Q) makes the stock's valuation appear attractive relative to its trailing 12-month EPS growth of 4.8%.
This is a classic disconnect: the market often rewards backward-looking momentum while pricing in optimistic forward assumptions. TXN's recent cost leverage and revenue growth are real, but they rest partly on capacity utilization that is strong but not infinite. As semiconductor supply chains normalize and competitive pressure returns, the cost ratio will likely revert toward longer-term averages. At that point, the valuation multiple may compress faster than earnings expand.
The Free Cash Flow Anomaly
One bright spot: free cash flow growth is outpacing earnings growth. On a year-over-year basis, FCF expanded 73.8%, far exceeding the 4.8% EPS growth. This reflects strong operating cash conversion ($2.703 billion in Q2 2026 operating cash flow) and disciplined capex (averaging roughly $600-700 million per quarter).
However, this is partly a function of the low base in 2025 (when capex exceeded $4.55 billion for the full year as TXN invested in manufacturing capacity). The company is now harvesting that investment, but the underlying capex intensity suggests future years will require continued heavy spending to maintain competitive manufacturing technology. Free cash flow yields of 2.1%, while respectable, offer limited margin of safety if earnings revert.
What the Numbers Actually Show
Bottom Line
Texas Instruments is a well-run semiconductor company with genuine engineering moats and manufacturing expertise. The Q2 2026 results demonstrate competent execution in a favorable market. But the headline earnings acceleration masks a more pedestrian story: margins are leveraging up as capacity utilization peaks, capital allocation is conservative, and valuation multiples appear stretched relative to underlying growth. Investors should distinguish between quarterly momentum and durable competitive advantage. TXN has the latter, but not enough of it to justify current valuations if the cycle turns.